Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment

被引：39

作者：

Rashid, Zainab Ahmed ^{[1
]}

Bardaweel, Sanaa K. ^{[1
]}

机构：

[1] Univ Jordan, Sch Pharm, Dept Pharmaceut Sci, Amman 11942, Jordan

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 15期

关键词：

MMP-9; matrix metalloproteinase; inhibitors; molecular docking; anticancer; MATRIX-METALLOPROTEINASE INHIBITOR; CLINICAL-TRIALS GROUP; AIDED DRUG DESIGN; PHASE-I TRIAL; GELATINASE-B; HYDROXAMATE INHIBITORS; MOLECULAR DOCKING; BIOLOGICAL EVALUATION; ORTHOTOPIC MODEL; BATIMASTAT BB-94;

D O I：

10.3390/ijms241512133

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Matrix metalloproteinases (MMPs) belong to a family of zinc-dependent proteolytic metalloenzymes. MMP-9, a member of the gelatinase B family, is characterized as one of the most intricate MMPs. The crucial involvement of MMP-9 in extracellular matrix (ECM) remodeling underscores its significant correlation with each stage of cancer pathogenesis and progression. The design and synthesis of MMP-9 inhibitors is a potentially attractive research area. Unfortunately, to date, there is no effective MMP-9 inhibitor that passes the clinical trials and is approved by the FDA. This review primarily focuses on exploring the diverse strategies employed in the design and advancement of MMP-9 inhibitors, along with their anticancer effects and selectivity. To illuminate the essential structural characteristics necessary for the future design of novel MMP-9 inhibitors, the current narrative review highlights several recently discovered MMP-9 inhibitors exhibiting notable selectivity and potency.

引用

页数：24

共 168 条

[11] The Association of MMP-9 Enzyme Activity, MMP-9 C1562T Polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 Gene Expression in Lung Cancer [J].

Bayramoglu, Aysegul ;

Gunes, Hasan Veysi ;

Metintas, Muzaffer ;

Degirmenci, Irfan ;

Mutlu, Fezan ;

Alatas, Fusun .

GENETIC TESTING AND MOLECULAR BIOMARKERS, 2009, 13 (05) :671-678

[12]

Beattie GJ, 1998, CLIN CANCER RES, V4, P1899

[13] Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease [J].

Becker, Daniel P. ;

Barta, Thomas E. ;

Bedell, Louis J. ;

Boehm, Terri L. ;

Bond, Brian R. ;

Carroll, Jeffery ;

Carron, Chris P. ;

DeCrescenzo, Gary A. ;

Easton, Alan M. ;

Freskos, John N. ;

Funckes-Shippy, Chris L. ;

Heron, Marcia ;

Hockerman, Susan ;

Howard, Carol Pearcy ;

Kiefer, James R. ;

Li, Madeleine H. ;

Mathis, Karl J. ;

McDonald, Joseph J. ;

Mehta, Pramod P. ;

Munie, Grace E. ;

Sunyer, Teresa ;

Swearingen, Craig A. ;

Villamil, Clara I. ;

Welsch, Dean ;

Williams, Jennifer M. ;

Yu, Ying ;

Yao, Jun .

JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (18) :6653-6680

[14] New matrix metalloproteinase inhibitors based on γ-fluorinated α-aminocarboxylic and α-aminohydroxamic acids [J].

Behrends, Malte ;

Wagner, Stefan ;

Kopka, Klaus ;

Schober, Otmar ;

Schaefers, Michael ;

Kumbhar, Sadhana ;

Waller, Mark ;

Haufe, Guenter .

BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) :3809-3818

[15] Venous thromboembolism among patients with advanced lung cancer randomized to prinomastat or placebo, plus chemotherapy [J].

Behrendt, CE ;

Ruiz, RB .

THROMBOSIS AND HAEMOSTASIS, 2003, 90 (04) :734-737

[16] New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors [J].

Beutel, Bernd ;

Song, Jian ;

Konken, Christian Paul ;

Korpos, Eva ;

Schinor, Benjamin ;

Gerwien, Hanna ;

Vidyadharan, Reshma ;

Burmeister, Miriam ;

Li, Lixia ;

Haufe, Guenter ;

Sorokin, Lydia .

BIOCONJUGATE CHEMISTRY, 2018, 29 (11) :3715-3725

[17] Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer [J].

Bissett, D ;

O'Byrne, KJ ;

von Pawel, J ;

Gatzemeier, U ;

Price, A ;

Nicolson, M ;

Mercier, R ;

Mazabel, E ;

Penning, C ;

Zhang, MH ;

Collier, MA ;

Shepherd, FA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :842-849

[18] Gelatinase-mediated migration and invasion of cancer cells [J].

Björklund, M ;

Koivunen, E .

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1755 (01) :37-69

[19] C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging [J].

Breyholz, HJ ;

Schäfers, M ;

Wagner, S ;

Höltke, C ;

Faust, A ;

Rabeneck, H ;

Levkau, B ;

Schober, O ;

Kopka, K .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (09) :3400-3409

[20] Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development [J].

Bronisz, Elzbieta ;

Kurkowska-Jastrzebska, Iwona .

MEDIATORS OF INFLAMMATION, 2016, 2016

← 1 2 3 4 5 6 7 8 9 10 →